Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Pharmacology and Legislative Developments in Canada

Clinical Pharmacology and Legislative Developments in Canada J. CORBOY RYAN M.D. 1 , and W. G. BRUCE CASSELMAN M.D., Ph.D. 2 1 Chief. Division of Medicine and Pharmacology 2 Head, Clinical Pharmacology Section, Division of Medicine and Pharmacology, Food and Drug Directorate, Tunney's Pasture, Ottawa, Ontario, Canada The progression of pharmacology and therapeutics towards a unifying position among the medical sciences has been accompanied by the emergence of clinical pharmacology as a distinct interdisciplinary entity. The continued development of clinical pharmacology not only depends upon adequate training and research facilities and financial support, but also needs favorable legislation. In recognition of this need, a Special Committee was appointed in Canada to study existing legislation on investigational drugs. This Committee recommended distinction between, and separate regulations for, clinical pharmacology and therapeutic trials. New regulations are expected to be introduced shortly that will facilitate clinical pharmacological investigations and, therefore, contribute to the further development of clinical pharmacology in Canada. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychosomatics American Psychiatric Publishing, Inc (Journal)

Clinical Pharmacology and Legislative Developments in Canada

Psychosomatics , Volume 12 (4): 231 – Jul 1, 1971

Clinical Pharmacology and Legislative Developments in Canada

Psychosomatics , Volume 12 (4): 231 – Jul 1, 1971

Abstract

J. CORBOY RYAN M.D. 1 , and W. G. BRUCE CASSELMAN M.D., Ph.D. 2 1 Chief. Division of Medicine and Pharmacology 2 Head, Clinical Pharmacology Section, Division of Medicine and Pharmacology, Food and Drug Directorate, Tunney's Pasture, Ottawa, Ontario, Canada The progression of pharmacology and therapeutics towards a unifying position among the medical sciences has been accompanied by the emergence of clinical pharmacology as a distinct interdisciplinary entity. The continued development of clinical pharmacology not only depends upon adequate training and research facilities and financial support, but also needs favorable legislation. In recognition of this need, a Special Committee was appointed in Canada to study existing legislation on investigational drugs. This Committee recommended distinction between, and separate regulations for, clinical pharmacology and therapeutic trials. New regulations are expected to be introduced shortly that will facilitate clinical pharmacological investigations and, therefore, contribute to the further development of clinical pharmacology in Canada.

Loading next page...
 
/lp/american-psychiatric-publishing-inc-journal/clinical-pharmacology-and-legislative-developments-in-canada-bRMJIgUiYz

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Psychiatric Publishing, Inc (Journal)
Copyright
Copyright © 1971 Academy of Psychosomatic Medicine. All rights reserved.
ISSN
0033-3182
DOI
10.1176/appi.psy.12.4.231
Publisher site
See Article on Publisher Site

Abstract

J. CORBOY RYAN M.D. 1 , and W. G. BRUCE CASSELMAN M.D., Ph.D. 2 1 Chief. Division of Medicine and Pharmacology 2 Head, Clinical Pharmacology Section, Division of Medicine and Pharmacology, Food and Drug Directorate, Tunney's Pasture, Ottawa, Ontario, Canada The progression of pharmacology and therapeutics towards a unifying position among the medical sciences has been accompanied by the emergence of clinical pharmacology as a distinct interdisciplinary entity. The continued development of clinical pharmacology not only depends upon adequate training and research facilities and financial support, but also needs favorable legislation. In recognition of this need, a Special Committee was appointed in Canada to study existing legislation on investigational drugs. This Committee recommended distinction between, and separate regulations for, clinical pharmacology and therapeutic trials. New regulations are expected to be introduced shortly that will facilitate clinical pharmacological investigations and, therefore, contribute to the further development of clinical pharmacology in Canada.

Journal

PsychosomaticsAmerican Psychiatric Publishing, Inc (Journal)

Published: Jul 1, 1971

There are no references for this article.